Hong Kong stock unusual movement | Rongchang Biotechnology (09995.HK) surged over 8% with Taijia Sip GMG China Phase III clinical study selected for 2025 AANEM oral presentation.

According to the Securities Times app, Rongchang Biotech (09995.HK) has risen by over 8%, as of the time of filing, it has risen by 8.29% to HK$115, with a trading volume of HK$2.22 billion.